Quantcast

Latest Personalized medicine Stories

2014-08-01 12:26:23

CHICAGO, Aug. 1, 2014 /PRNewswire-USNewswire/ -- One of the major revolutions taking place in healthcare is the rise of personalized medicine, which is the practice of using genomic and other molecular analyses to tailor medical treatments to a patient's individual biology. Personalized diagnostics--laboratory analyses that inform the practice of personalized medicine--will play a major role in the lab's future. This fall, AACC's first ever virtual conference will feature the latest...

2014-07-31 23:13:21

New Market Research Reports Title “Global Molecular Diagnostics Market Analysis Size And Segment Forecasts To 2020” Has Been Added to GrandViewReseach.com Report Database. View Full Report With TOC @ http://www.grandviewresearch.com/industry-analysis/molecular-diagnostics-market. (PRWEB) July 31, 2014 The global market for molecular diagnostics is expected to reach USD 8,020.1 million by 2020, according to a new study by Grand View Research, Inc. Growing demand for personalized...

2014-07-31 12:29:39

Investment from Blue Cross Blue Shield of Massachusetts subsidiary will strengthen genetic benefits services ST. PETERSBURG, Fla., July 31, 2014 /PRNewswire-USNewswire/ -- InformedDNA, a leading provider of Genetic Benefits Management and the largest independent network of genetic specialists in the U.S., announced today that it has reached a $4.5 million funding agreement with Zaffre Investments, a wholly owned subsidiary of Blue Cross Blue Shield of Massachusetts. InformedDNA will...

2014-07-30 08:32:03

Investment will support scale of global services, development of independent diagnostic tests, and deployment of future companion diagnostic products SAN DIEGO, July 30, 2014 /PRNewswire/ -- Epic Sciences, Inc. ("Epic"), a privately held biotech company that designs and develops novel diagnostics to personalize and advance the treatment and management of cancer, announced today the completion of a $30 million Series C Preferred Stock financing. The financing included new investors...

2014-07-30 08:31:59

SAN DIEGO, July 30, 2014 /PRNewswire/ -- Epic Sciences, Inc. ("Epic"), a private biotech company that designs and develops novel diagnostics to personalize and advance the treatment and management of cancer, announced today the appoint of Gregory T. Lucier as chairman of Epic's board of directors. Mr. Lucier was previously chairman and CEO of Life Technologies (formerly Invitrogen). Mr. Lucier joins Epic's board of directors to provide expertise as Epic commercializes its circulating...

2014-07-24 23:14:07

Bio-ID Diagnostics Inc., the parent company of MultiGEN Diagnostics Inc., has been awarded a US patent for broad based QC/QA applications in clinical diagnostic testing. This can eliminate false negatives and provide novel features for sample tracking. San Diego, CA (PRWEB) July 24, 2014 The patent provides substantially greater confidence in the reporting of molecular diagnostic test results. It also enables true sample ID and superior tracking capabilities necessary for the validation...

2014-07-24 23:09:34

GIA announces the release of a comprehensive global report on Molecular Diagnostics markets. Global market for Molecular Diagnostics is projected to reach US$10.7 billion by 2020, driven by aging population, increasing prevalence of chronic and life-threatening diseases, growing need for better disease diagnostics, and advancements in proteomics and genomics. San Jose, California (PRWEB) July 24, 2014 Follow us on LinkedIn – Molecular diagnosis represents a rapidly expanding sector in...

2014-07-24 16:27:48

MADISON, Wis., July 24, 2014 /PRNewswire/ -- Restore Health, a leading personalized medicine company that provides specialty and compounded pharmaceuticals, announced that it is now offering pharmacogenetics testing that provides drug sensitivity information unique to each individual based upon their particular genetic makeup. Comprehensive medication management is now possible by understanding the interaction between a patient's genetics and their entire drug regimen....

2014-07-23 23:20:10

Transparency Market Research published a new report "Molecular Diagnostics Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019" to its report store. Browse the full report: http://www.transparencymarketresearch.com/molecular-diagnostics-industry.html. Albany, New York (PRWEB) July 22, 2014 Transparency Market Research has announced the addition of a new market report based on Molecular Diagnostics Market – Global Industry Analysis, Size,...

2014-07-18 12:24:50

OmniSeq Target(TM) testing to guide treatment decisions for patients with lung cancer and other solid tumors BUFFALO, N.Y., July 18, 2014 /PRNewswire-USNewswire/ -- The New York State Department of Health (DOH) has granted Roswell Park Cancer Institute (RPCI) approval to begin genomic testing of cancer patients using its OmniSeq Target(TM) advanced molecular diagnostic laboratory test. The test, approved through the DOH's Clinical Laboratory Evaluation Program (CLEP), is part of a...


Word of the Day
barratry
  • The offense of persistently instigating lawsuits, typically groundless ones.
  • An unlawful breach of duty on the part of a ship's master or crew resulting in injury to the ship's owner.
  • Sale or purchase of positions in church or state.
This word ultimately comes from the Old French word 'barater,' to cheat.
Related